Clinical Trial Update: Combination Therapy in Patients With Relapsing-Remitting Multiple Sclerosis (MS)CombiRx [Phase 3]

View source ↗

Summary

Phase 3 MSCombiRx trial evaluating combination therapy with interferon beta-1a and glatiramer acetate in relapsing-remitting multiple sclerosis has completed an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Relapsing-remitting Multiple Sclerosis

Drugs mentioned

• COPAXONE (GLATIRAMER ACETATE)
• Rebif (interferon beta-1a)

Snippet

Sponsor: Fred Lublin | Conditions: Relapsing Remitting Multiple Sclerosis | Phase 3 | Status: COMPLETED | Results posted: 2014-04-03